AngioScore has announced the launch of its new 100mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral arterial disease (PAD) below the knee (BTK).
Gore has introduced the Gore DrySeal sheath with hydrophilic coating in Europe. The new Gore DrySeal Sheath allows for easier insertion into and removal from blood vessels during endovascular repair procedures. The device is designed to increase sheath lubricity with an advantage of minimizing particulation of the hydrophilic coating.
Covidien announced on 23 January 2013 CE mark approval for its EverFlex self-expanding peripheral stent with Entrust delivery system. The advanced stent delivery system, specifically engineered for optimal control, is designed to allow physicians to consistently place stents in the desired location with accuracy and ease. The product will be rolled out in Western Europe next month.
Cardiovascular Systems announced on 23 January 2013 CONFIRM study series data presented at the 2013 International Symposium on Endovascular Therapy (ISET). Results show that CSI’s minimally invasive orbital atherectomy system is an effective treatment for peripheral arterial disease.
Spectranetics announced on 24 January 2013 final results from the PATENT (Photo-ablation using the Turbo-Booster and Excimer laser for in-stent restenosis treatment) study evaluating the safety and efficacy of the Spectranetics peripheral laser atherectomy catheters for the treatment of in-stent restenosis in the femoropopliteal artery in the leg.
Medtronic has announced the CE mark and international launch of its Complete SE (self-expanding) vascular stent for use in the lower extremities – specifically, the superficial femoral arteries and proximal popliteal arteries. In the United States, the Complete SE stent is approved by the FDA only for use in the iliac arteries.
Endologix announced on 24 January 2013 achievement of the CE mark of the Nellix EndoVascular Aneurysm Sealing System for the treatment of patients with abdominal aortic aneurysms. Nellix is the first available endovascular aneurysm sealing (EVAS) system. EVAS with Nellix is an advanced treatment strategy designed to simplify endovascular abdominal aortic aneurysm procedures, treat a broad range of patients, and provide enhanced clinical outcomes. The Nellix system is not approved in the United States for either investigational use or commercial sale.
Los pacientes con las arterias de las piernas bloqueadas tienen menos probabilidades de sufrir complicaciones tras un procedimiento para abrir sus arterias si dejan de fumar y toman aspirina y estatinas para reducir el colesterol, indica un estudio reciente.
On 21 January 2013, TriVascular announced FDA approval of the Ovation Prime Abdominal Stent Graft System for the treatment of abdominal aortic aneurysms. Ovation Prime builds upon the strong clinical experience of TriVascular’s Ovation stent graft by improving delivery system attributes to further enhance ease of use. Delivered through a 14F (4.7mm) outer diameter catheter, Ovation Prime is the lowest profile commercially available system for endovascular aortic repair (EVAR).
Eurocor unveiled interim results of the ongoing Freeway Stent Study on 17 January 2013 at IROS (Interventionell Radiologische Olbert Symposium), Berlin, Germany. The study was presented during the Free Paper Session 2 by Josef Tacke, Klinikum Passau, Germany. The multicentre, open, prospective randomised trial investigates the prevention of restenosis by drug-eluting balloon dilatation (Freeway) after stenting with a nitinol stent versus dilatation with standard balloon angioplasty after stenting with a nitinol stent in the treatment of superficial femoral artery or popliteal artery lesions.
Las mujeres con un trastorno hormonal llamado síndrome de ovario poliquístico (SOP) y que usan píldoras anticonceptivas tienen el doble de riesgo de desarrollar coagulos sanguíneos que otras usuarias de la píldora.
AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK)
Expanding its role in the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced the CE (Conformité Européene) mark and international launch of its Complete SE (self-expanding) vascular stent for use in the lower extremities –– specifically, the superficial femoral arteries (SFA) and proximal popliteal arteries (PPA), which supply blood to the legs.
Gore has received Food and Drug Administration (FDA) approval for the new large diameter 35mm trunk-ipsilateral leg and 36mm aortic extender components, as well as the lower profile 31mm diameter trunk-ipsilateral leg and 32mm aortic extender components of the Gore Excluder AAA Endoprosthesis. According to the company, the new components provide physicians with a proven and durable endovascular option to treat abdominal aortic aneurysms (AAA).
Gore has announced the availability of the new Q50 PLUS Stent Graft Balloon Catheter. According to a company release, the new device features enhanced radial expansion force to aid in endograft modeling and sealing, and a new stopcock design to improve operator control.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos